NYSE:HRC - Hill-Rom Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $104.2450 -0.36 (-0.34 %) (As of 02/19/2019 02:39 PM ET)Previous Close$104.61Today's Range$103.9350 - $104.737852-Week Range$80.70 - $105.78Volume185,296 shsAverage Volume570,253 shsMarket Capitalization$6.95 billionP/E Ratio21.95Dividend Yield0.77%Beta0.95 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as blood pressure, physical assessment, vital signs monitoring, diagnostic cardiopulmonary, diabetic retinopathy screening, and thermometry products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, and Monarch systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables; and operating room surgical safety and accessory products, which comprise scalpels and blades, light handle systems, skin markers, and other disposable products. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois. Receive HRC News and Ratings via Email Sign-up to receive the latest news and ratings for HRC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:HRC Previous SymbolNYSE:HB CUSIP43147510 Webwww.hill-rom.com Phone312-819-7200Debt Debt-to-Equity Ratio1.17 Current Ratio1.70 Quick Ratio1.25Price-To-Earnings Trailing P/E Ratio21.95 Forward P/E Ratio20.60 P/E Growth1.46 Sales & Book Value Annual Sales$2.47 billion Price / Sales2.81 Cash Flow$7.9698 per share Price / Cash Flow13.08 Book Value$23.27 per share Price / Book4.48Profitability EPS (Most Recent Fiscal Year)$4.75 Net Income$252.40 million Net Margins7.21% Return on Equity21.23% Return on Assets7.43%Miscellaneous Employees10,000 Outstanding Shares66,664,000Market Cap$6.95 billion OptionableOptionable Hill-Rom (NYSE:HRC) Frequently Asked Questions What is Hill-Rom's stock symbol? Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC." How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom? Hill-Rom announced a quarterly dividend on Thursday, November 8th. Investors of record on Friday, December 14th will be paid a dividend of $0.20 per share on Monday, December 31st. This represents a $0.80 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date is Thursday, December 13th. View Hill-Rom's Dividend History. How were Hill-Rom's earnings last quarter? Hill-Rom Holdings, Inc. (NYSE:HRC) released its quarterly earnings results on Friday, January, 25th. The medical technology company reported $1.02 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.98 by $0.04. The medical technology company earned $683.50 million during the quarter, compared to analysts' expectations of $676.39 million. Hill-Rom had a net margin of 7.21% and a return on equity of 21.23%. The company's revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.92 earnings per share. View Hill-Rom's Earnings History. When is Hill-Rom's next earnings date? Hill-Rom is scheduled to release their next quarterly earnings announcement on Friday, April 26th 2019. View Earnings Estimates for Hill-Rom. What guidance has Hill-Rom issued on next quarter's earnings? Hill-Rom updated its FY19 earnings guidance on Friday, January, 25th. The company provided EPS guidance of $4.98-5.06 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.14. The company issued revenue guidance of $2.88-2.9 billion (+1-2%), compared to the consensus revenue estimate of $2.90 billion.Hill-Rom also updated its FY 2019 guidance to $4.98-5.06 EPS. What price target have analysts set for HRC? 8 brokers have issued 12-month price objectives for Hill-Rom's shares. Their predictions range from $85.00 to $115.00. On average, they expect Hill-Rom's stock price to reach $102.8750 in the next twelve months. This suggests that the stock has a possible downside of 1.2%. View Analyst Price Targets for Hill-Rom. What is the consensus analysts' recommendation for Hill-Rom? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Hill-Rom. Has Hill-Rom been receiving favorable news coverage? News coverage about HRC stock has been trending somewhat positive on Tuesday, InfoTrie reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Hill-Rom earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave news stories about the medical technology company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term. Who are some of Hill-Rom's key competitors? Some companies that are related to Hill-Rom include ABIOMED (ABMD), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Penumbra (PEN), ICU Medical (ICUI), Insulet (PODD), Novocure (NVCR), Globus Medical (GMED), Haemonetics (HAE), Integra Lifesciences (IART), Cantel Medical (CMD), Merit Medical Systems (MMSI), NuVasive (NUVA) and Tandem Diabetes Care (TNDM). Who are Hill-Rom's key executives? Hill-Rom's management team includes the folowing people: Ms. Deborah M. Rasin, Sr. VP, Chief Legal Officer & Sec. (Age 51)Mr. Carlos Alonso-Marum, Sr. VP & Pres of International (Age 59)Mr. Steven J. Strobel, Sr. Advisor (Age 60)Mr. John P. Groetelaars, Pres, CEO & Director (Age 51)Ms. Barbara W. Bodem, Sr. VP & CFO (Age 50) Who are Hill-Rom's major shareholders? Hill-Rom's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.53%), Oregon Public Employees Retirement Fund (3.46%), Bank of Montreal Can (2.44%), Fisher Asset Management LLC (1.97%), Lord Abbett & CO. LLC (1.70%) and Bank of New York Mellon Corp (1.56%). Company insiders that own Hill-Rom stock include Alton Shader, Andreas G Frank, Deborah Rasin, John J Greisch, Mary Garrett and Paul Sherwood Johnson. View Institutional Ownership Trends for Hill-Rom. Which major investors are selling Hill-Rom stock? HRC stock was sold by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., Bank of America Corp DE, Lord Abbett & CO. LLC, Bank of Montreal Can, Jennison Associates LLC, Thrivent Financial for Lutherans, Prudential PLC and Royce & Associates LP. Company insiders that have sold Hill-Rom company stock in the last year include Alton Shader, Andreas G Frank, Deborah Rasin and Paul Sherwood Johnson. View Insider Buying and Selling for Hill-Rom. Which major investors are buying Hill-Rom stock? HRC stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Bank of New York Mellon Corp, BlackRock Inc., Two Sigma Investments LP, Channing Capital Management LLC, Squarepoint Ops LLC, Mackay Shields LLC and Mountain Pacific Investment Advisers Inc. ID. View Insider Buying and Selling for Hill-Rom. How do I buy shares of Hill-Rom? Shares of HRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Hill-Rom's stock price today? One share of HRC stock can currently be purchased for approximately $104.10. How big of a company is Hill-Rom? Hill-Rom has a market capitalization of $6.94 billion and generates $2.47 billion in revenue each year. The medical technology company earns $252.40 million in net income (profit) each year or $4.75 on an earnings per share basis. Hill-Rom employs 10,000 workers across the globe. What is Hill-Rom's official website? The official website for Hill-Rom is http://www.hill-rom.com. How can I contact Hill-Rom? Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at 312-819-7200 or via email at [email protected] MarketBeat Community Rating for Hill-Rom (NYSE HRC)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 325 (Vote Outperform)Underperform Votes: 340 (Vote Underperform)Total Votes: 665MarketBeat's community ratings are surveys of what our community members think about Hill-Rom and other stocks. Vote "Outperform" if you believe HRC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HRC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/19/2019 by MarketBeat.com StaffFeatured Article: What is a Lock-Up Period?